反应详情

The title compound was prepared following the procedure of example two with N5-(2-chloro-pyrimidin-4-yl)-N2-(4-fluoro-benzyl)-1,N5-dimethyl-1H-benzoimidazole-2,5-diamine (99 mg, 0.25 mmol) and 4-[(methylsulfonyl)methyl]aniline (46 mg, 0.25 mmol) as a white solid (69 mg, 48%). 1H NMR (300 MHz, d6-DMSO) δ 9.20 (s, 1H), 7.76-7.80 (m, 3H), 7.41-7.46 (m, 3H), 7.23 (d, J=8.4 Hz, 3H), 7.09-7.17 (m, 3H), 6.84 (dd, J=8.4 and 1.8 Hz, 1H), 5.63 (d, J=6.0 Hz, 1H), 4.57 (d, J=5.7 Hz, 2H), 4.34 (s, 2H), 3.57 (s, 3H), 3.43 (s, 3H), 2.85 (s, 3H). MS (ESI) m/z=546 [M+H]+.